449 related articles for article (PubMed ID: 19429441)
1. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action.
Kerachian MA; Séguin C; Harvey EJ
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):121-8. PubMed ID: 19429441
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head.
Yang N; Sun H; Xue Y; Zhang W; Wang H; Tao H; Liang X; Li M; Xu Y; Chen L; Zhang L; Huang L; Geng D
Clin Transl Med; 2021 Jun; 11(6):e447. PubMed ID: 34185425
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid induces osteonecrosis of the femoral head in rats through GSK3β-mediated osteoblast apoptosis.
Nie Z; Chen S; Peng H
Biochem Biophys Res Commun; 2019 Apr; 511(3):693-699. PubMed ID: 30827503
[TBL] [Abstract][Full Text] [Related]
4. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis.
Zalavras C; Shah S; Birnbaum MJ; Frenkel B
Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):221-35. PubMed ID: 14696969
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head.
Varoga D; Drescher W; Pufe M; Groth G; Pufe T
Clin Orthop Relat Res; 2009 Dec; 467(12):3273-82. PubMed ID: 19763724
[TBL] [Abstract][Full Text] [Related]
6. PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway.
Yao X; Yu S; Jing X; Guo J; Sun K; Guo F; Ye Y
Stem Cell Res Ther; 2020 Mar; 11(1):140. PubMed ID: 32228695
[TBL] [Abstract][Full Text] [Related]
7. The Pathophysiological Sequence of Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Male Mice.
Weinstein RS; Hogan EA; Borrelli MJ; Liachenko S; O'Brien CA; Manolagas SC
Endocrinology; 2017 Nov; 158(11):3817-3831. PubMed ID: 28938402
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucocorticoids on the function of microvascular endothelial cells in the human femoral head bone.
Lu Y; Yu Q; Guo W; Hao Y; Sun W; Cheng L
Adv Clin Exp Med; 2020 Mar; 29(3):345-353. PubMed ID: 32237286
[TBL] [Abstract][Full Text] [Related]
9. Exosomes derived from human CD34
Zuo R; Kong L; Wang M; Wang W; Xu J; Chai Y; Guan J; Kang Q
Stem Cell Res Ther; 2019 Nov; 10(1):321. PubMed ID: 31730486
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway.
Jiang Y; Zhang Y; Zhang H; Zhu B; Li P; Lu C; Xu Y; Chen W; Lin N
Exp Biol Med (Maywood); 2014 Mar; 239(3):347-55. PubMed ID: 24510055
[TBL] [Abstract][Full Text] [Related]
11. Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.
Bejar J; Peled E; Boss JH
Theor Biol Med Model; 2005 Jul; 2():24. PubMed ID: 15996271
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles from human urine-derived stem cells inhibit glucocorticoid-induced osteonecrosis of the femoral head by transporting and releasing pro-angiogenic DMBT1 and anti-apoptotic TIMP1.
Chen CY; Du W; Rao SS; Tan YJ; Hu XK; Luo MJ; Ou QF; Wu PF; Qing LM; Cao ZM; Yin H; Yue T; Zhan CH; Huang J; Zhang Y; Liu YW; Wang ZX; Liu ZZ; Cao J; Liu JH; Hong CG; He ZH; Yang JX; Tang SY; Tang JY; Xie H
Acta Biomater; 2020 Jul; 111():208-220. PubMed ID: 32447063
[TBL] [Abstract][Full Text] [Related]
14. Role of coagulopathy in glucocorticoid-induced osteonecrosis of the femoral head.
Zhang Q; L V J; Jin L
J Int Med Res; 2018 Jun; 46(6):2141-2148. PubMed ID: 28459353
[TBL] [Abstract][Full Text] [Related]
15. Experimentally gained insight - based proposal apropos the treatment of osteonecrosis of the femoral head.
Boss JH; Misselevich I; Bejar J; Norman D; Zinman C; Reis DN
Med Hypotheses; 2004; 62(6):958-65. PubMed ID: 15142657
[TBL] [Abstract][Full Text] [Related]
16. Porous, lithium-doped calcium polyphosphate composite scaffolds containing vascular endothelial growth factor (VEGF)-loaded gelatin microspheres for treating glucocorticoid-induced osteonecrosis of the femoral head.
Luo Y; Li D; Xie X; Kang P
Biomed Mater; 2019 Apr; 14(3):035013. PubMed ID: 30802884
[TBL] [Abstract][Full Text] [Related]
17. Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats.
Chen S; Li J; Peng H; Zhou J; Fang H
Int J Mol Med; 2014 Apr; 33(4):840-8. PubMed ID: 24503957
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid inhibits bone regeneration after osteonecrosis of the femoral head in aged female rats.
Takano-Murakami R; Tokunaga K; Kondo N; Ito T; Kitahara H; Ito M; Endo N
Tohoku J Exp Med; 2009 Jan; 217(1):51-8. PubMed ID: 19155608
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PERK Signaling Prevents Against Glucocorticoid-induced Endotheliocyte Apoptosis and Osteonecrosis of the Femoral Head.
Gao Y; Zhu H; Wang Q; Feng Y; Zhang C
Int J Biol Sci; 2020; 16(4):543-552. PubMed ID: 32025204
[TBL] [Abstract][Full Text] [Related]
20. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling.
Jiang Y; Zhang Y; Chen W; Liu C; Li X; Sun D; Liu Z; Xu Y; Mao X; Guo Q; Lin N
J Transl Med; 2014 Nov; 12():334. PubMed ID: 25471933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
